ClinVar Miner

Submissions for variant NM_194248.3(OTOF):c.4552G>A (p.Ala1518Thr)

gnomAD frequency: 0.00020  dbSNP: rs145556189
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000825997 SCV000967485 uncertain significance not specified 2018-09-17 criteria provided, single submitter clinical testing The p.Ala1518Thr variant in OTOF has not been previously reported in individuals with hearing loss or auditory neuropathy spectrum disorder but has been identif ied in 0.058% (14/24028) African chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). Computational prediction tools and c onservation analysis suggest that the p.Ala1518Thr variant may not impact the pr otein, though this information is not predictive enough to rule out pathogenicit y. In summary, the clinical significance of the p.Ala1518Thr variant is uncertai n. ACMG/AMP Criteria applied: BP4, PM2_Supporting.
GeneDx RCV001772151 SCV001994595 uncertain significance not provided 2022-08-12 criteria provided, single submitter clinical testing In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Ambry Genetics RCV002536074 SCV003728554 uncertain significance Inborn genetic diseases 2021-07-21 criteria provided, single submitter clinical testing The c.4552G>A (p.A1518T) alteration is located in exon 37 (coding exon 37) of the OTOF gene. This alteration results from a G to A substitution at nucleotide position 4552, causing the alanine (A) at amino acid position 1518 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Invitae RCV001772151 SCV004284462 benign not provided 2023-12-18 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.